## Abstract Thirty‐five thyroid tumors and four normal thyroids were immunohistochemically investigated for the presence of laminin, a major basement membrane component. The thyroid follicles in normal tissues and in nodular goiters were surrounded by a continuous rim of laminin positivity, as were
Expression of galectin-1 in normal human thyroid gland and in differentiated and poorly differentiated thyroid tumors
✍ Scribed by Lorenzo Chiariotti; Maria Teresa Berlingieri; Caterina Battaglia; Giovanna Benvenuto; Maria Luisa Martelli; Paola Salvatore; Gennaro Chiappettaxy; Carmelo Bruno Bruni; Alfredo Fusco
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- French
- Weight
- 934 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
We previously reported that galectin‐l gene expression increases up to 100‐fold in oncogene‐transformed rat thyroid cells compared with their normal counterparts and that the relative mRNA levels correlate with the degree of malignancy. In the present study we investigated whether galectin‐l is differentially expressed in human thyroid neoplasms, which range from well‐differentiated tumors to undifferentiated ana‐plastic carcinomas. We analyzed 74 human thyroid specimens of neoplastic, hyperproliferative and normal tissues and several tumor cell lines. Galectin‐l mRNA and protein levels were higher in 6 thyroid carcinoma‐derived cell lines than in normal thyroid primary cultures and adenoma cells. Galectin‐l mRNA levels increased in 28/40 papillary carcinomas and in 6/7 anaplastic carcinomas compared with normal or hyperplastic thyroid. Conversely, galectin‐l expression was unaffected in follicular carcinomas and benign adenomas. Immunohistochemi‐cal analysis of normal thyroid and papillary carcinoma sections revealed a higher content of galectin‐l protein in neoplastic follicular cells than in normal cells. © 1995 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Human thyroid cells in culture take up and organify ^125^I when cultured in TSH (acting through cAMP) and insulin. They also secrete urokinase (uPA) and tissue‐type (tPA) plasminogen activators (5–100 IU/10^6^cells/day). TSH and insulin both decreased secreted PA activity (PAA), uPA and
The p 16INK4 tumor-suppressor gene (also known as CDKNZ, CDK41 and MTSI) encodes a negative regulator of the cell cycle. This gene, located in 9pZ I, is mutated or homozygously deleted in a high percentage of tumor cell lines and specific types of primary tumors. We have examined the status of the p